The value of ROX index in evaluating the efficacy of high-flow nasal cannula oxygen therapy in patients with COVID-19

Da, Wei, He, YuanYuan, Wang, XiaoBo, Xu, AiHui, Li, YongHuai, Xu, Xihai, Zhang, Hong

Da, Wei, He, YuanYuan, Wang, XiaoBo, Xu, AiHui, Li, YongHuai, Xu, Xihai, Zhang, Hong.

Chinese Journal of Emergency Medicine ; 30(5):588-592, 2021.

Article Dans Chinois | GIM | ID: covidwho-2115878

ABSTRACT

ABSTRACT

Objective:

To assess the value of the ROX index in evaluating the efficacy of highflow nasal cannula oxygen therapy (HFNC) in patients with coronavirus infected disease (COVID-19).

Mots clés

7782-44-7; 50-21-5; human diseases; patients; coronavirus disease 2019; drug therapy; viral diseases; risk factors; oxygen; efficacy; therapy; retrospective studies; lactic acid; ventilation; thorax; lymphocytes; man; Severe acute respi

Texte intégral

Imprimer

XML

Texte intégral: Disponible Collection: Bases de données des oragnisations internationales Base de données: GIM Type d'étude: Études expérimentales langue: Chinois Revue: Chinese Journal of Emergency Medicine Année: 2021 Type de document: Article

Documents relatifs à ce sujet

MEDLINE

LILACS

LIS

Texte intégral

Imprimer

XML